← Leaderboards
Michael Gottesman
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceCellsAbcb1 GeneDrug ResistanceResistance MechanismMalignant NeoplasmsAbcg2 GeneGenesPatternAbcc1 GeneMulti-Drug ResistanceMolecularChemotherapyPharmaceutical PreparationsPhenotypeCancer CellUptakeCollaborationsCell LineP-GlycoproteinPlayBaseSamplingPhysiological
Grant awards (46)
Mechanisms of non-classical multidrug resistance in cancer$1,844,598
ZIA · FY2025 · CA · contact PI
Zebrafish model of blood-brain barrier to improve drug delivery to the brain$768,582
ZIA · FY2025 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$461,149
ZIA · FY2025 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,563,961
ZIA · FY2024 · CA · contact PI
Zebrafish model of blood-brain barrier to improve drug delivery to the brain$781,981
ZIA · FY2024 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$260,661
ZIA · FY2024 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,704,193
ZIA · FY2023 · CA · contact PI
Zebrafish model of blood-brain barrier to improve drug delivery to the brain$852,096
ZIA · FY2023 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$284,032
ZIA · FY2023 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,215,034
ZIA · FY2022 · CA · contact PI
Zebrafish model of blood-brain barrier to improve drug delivery to the brain$607,518
ZIA · FY2022 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$607,518
ZIA · FY2022 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$928,891
ZIA · FY2021 · CA · contact PI
Zebrafish model of blood-brain barrier to improve drug delivery to the brain$464,446
ZIA · FY2021 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$464,446
ZIA · FY2021 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$854,013
ZIA · FY2020 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$768,611
ZIA · FY2020 · CA · contact PI
Studies on drug resistance in HIV-related Kaposi sarcoma$85,402
ZIA · FY2020 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$863,153
ZIA · FY2019 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$776,838
ZIA · FY2019 · CA · contact PI
Studies on drug resistance in HIV-related Kaposi sarcoma$86,315
ZIA · FY2019 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,133,609
ZIA · FY2018 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$824,443
ZIA · FY2018 · CA · contact PI
Studies on drug resistance in HIV-related Kaposis sarcoma$103,056
ZIA · FY2018 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,402,654
ZIA · FY2017 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$818,215
ZIA · FY2017 · CA · contact PI
Studies on drug resistance in HIV-related Kaposis sarcoma$116,888
ZIA · FY2017 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,416,959
ZIA · FY2016 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$544,985
ZIA · FY2016 · CA · contact PI
Studies on drug resistance in HIV-related Kaposis sarcoma$217,993
ZIA · FY2016 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,215,165
ZIA · FY2015 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$405,055
ZIA · FY2015 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$1,433,179
ZIA · FY2014 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$477,726
ZIA · FY2014 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$905,230
ZIA · FY2013 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$880,230
ZIA · FY2013 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$908,705
ZIA · FY2012 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$908,705
ZIA · FY2012 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$741,838
ZIA · FY2011 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$741,838
ZIA · FY2011 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$1,158,177
ZIA · FY2010 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$772,117
ZIA · FY2010 · CA · contact PI
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells$1,297,144
ZIA · FY2009 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$864,763
ZIA · FY2009 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$673,907
Z01 · FY2008 · CA · contact PI
Mechanisms of non-classical multidrug resistance in cancer$664,041
Z01 · FY2007 · CA · contact PI